01/12/2006

http://pure.qub.ac.uk/portal/en/publications/efficacy-and-safety-of-first-or-secondline-irinotecan-cisplatin-and-mitomycin-in-mesothelioma(c3dd7083-e93d-4ad9-b79d-cf7ac4e87970).html

http://dx.doi.org/10.1002/cncr.22366

http://www.scopus.com/inward/record.url?scp=33846333186&partnerID=8YFLogxK

eng

info:eu-repo/semantics/restrictedAccess

Fennell , D , Steele , J P , Shamash , J , Evans , M T , Wells , P , Sheaff , M T , Rudd , R M & Stebbing , J 2006 , ' Efficacy and Safety of First- or Second-line Irinotecan, Cisplatin, and Mitomycin in Mesothelioma ' Cancer , vol 109(1) , no. 1 , pp. 93-99 . DOI: 10.1002/cncr.22366

article